Zev Wainberg, M.D. Co-Director UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Hematology Oncology David Geffen School Of Medicine At UCLA Discusses REACHIN Study Using Regorafenib In Biliary Tract Cancer. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com
Discussing REACHIN Study Using Regorafenib In Biliary Tract Cancer
